Price Alert: Shares of CytomX (CTMX) Trade 3.16% Higher at Midday May 13
Equities Staff Follow |Shares of CytomX Therapeutics Inc (NASDAQ: CTMX) climbed 3.16% Friday.
As of 11:52:33 est, CytomX sits at $1.79 and has climbed $0.055 per share.
CytomX has moved 28.98% over the last 30 days and has moved YTD 59.82% based on the previous close.
The company expects its next earnings on 2022-08-04.
For technical charts, analysis, and more on CytomX visit the company profile.
About CytomX Therapeutics Inc
CytomX is a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming lives with safer, more effective therapies. CytomX is developing a novel class of investigational conditionally activated antibody therapeutics, based on its Probody® technology platform, for the treatment of cancer. CytomX has strategic drug discovery and development collaborations with AbbVie, Amgen, Astellas, and Bristol Myers Squibb.
To get more information on CytomX Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: CytomX Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.
Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.
Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer